Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 1:18 pm Purchase | 2024-12-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Ikarian Capital, LLC | 394,255 9.990% | 394,255![]() (New Position) | Filing History |
| 2025-02-13 1:07 pm Purchase | 2024-12-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Ayrton Capital LLC | 403,650 9.900% | 403,650![]() (New Position) | Filing History |
| 2025-01-29 6:42 pm Purchase | 2024-12-31 | 13D | TRAWS PHARMA, INC PAR TRAW | ORBIMED ADVISORS LLC | 760,824 19.900% | 155,293![]() (+25.65%) | Filing History |
| 2025-01-08 9:28 pm Purchase | 2024-12-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Perceptive Advisors LLC | 386,555 9.900% | 386,555![]() (New Position) | Filing History |
| 2024-11-06 4:12 pm Purchase | 2024-09-16 | 13D | TRAWS PHARMA, INC PAR TRAW | ORBIMED ADVISORS LLC | 605,531 19.900% | 3,531![]() (+0.59%) | Filing History |
| 2024-09-23 6:44 pm Purchase | 2024-09-16 | 13D | TRAWS PHARMA, INC PAR TRAW | ORBIMED ADVISORS LLC | 602,000 19.900% | 602,000![]() (New Position) | Filing History |
| 2024-04-08 9:37 pm Purchase | 2024-04-01 | 13D | TRAWS PHARMA, INC. TRAW | Viriom Inc. | 117,381 11.600% | 117,381![]() (New Position) | Filing History |
| 2022-02-14 3:20 pm Sale | 2021-12-31 | 13G | TRAWS PHARMA, INC. TRAW | CVI Investments, Inc. | 0 0.000% | -47,000![]() (Position Closed) | Filing History |
| 2021-10-01 11:01 am Purchase | 2021-09-23 | 13G | TRAWS PHARMA, INC. TRAW | CVI Investments, Inc. | 47,000 5.700% | 47,000![]() (New Position) | Filing History |

